MECHANISMS OF DISEASE Graves' Ophthalmopathy

被引：1067

作者：

Bahn, Rebecca S. ^{[1
]}

机构：

[1] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 08期

关键词：

THYROID-ASSOCIATED OPHTHALMOPATHY; HUMAN ORBITAL FIBROBLASTS; THYROTROPIN RECEPTOR EXPRESSION; FACTOR-I RECEPTOR; T-CELL-ACTIVATION; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; PREADIPOCYTE FIBROBLASTS; CONNECTIVE-TISSUE; GLYCOSAMINOGLYCAN PRODUCTION;

D O I：

10.1056/NEJMra0905750

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article reviews the mechanisms that lead to the development of Graves' ophthalmopathy. A central feature in its development is autoimmunity that involves not only T cells, B cells, and macrophages but also fibroblasts and adipose tissue within the orbit. Intraorbital cytokine-mediated inflammation also has a prominent role. These recent findings suggest new ways of treating this debilitating disease. Copyright © 2010 Massachusetts Medical Society.

引用

页码：726 / 738

页数：13

共 122 条

[41] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].

FORMAN, BM ;

TONTONOZ, P ;

CHEN, J ;

BRUN, RP ;

SPIEGELMAN, BM ;

EVANS, RM .

CELL, 1995, 83 (05) :803-812

[42] Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy [J].

Gerding, MN ;

van der Meer, JWC ;

Broenink, M ;

Bakker, O ;

Wiersinga, WM ;

Prummel, MF .

CLINICAL ENDOCRINOLOGY, 2000, 52 (03) :267-271

[43]

GRAVES R., 1835, LONDON MED SURG J, V7, P516

[44] The role of CD40 ligand in costimulation and T-cell activation [J].

Grewal, IS ;

Flavell, RA .

IMMUNOLOGICAL REVIEWS, 1996, 153 :85-106

[45] DETECTION OF TSH RECEPTOR RNA IN CULTURED FIBROBLASTS FROM PATIENTS WITH GRAVES OPHTHALMOPATHY AND PRETIBIAL DERMOPATHY [J].

HEUFELDER, AE ;

DUTTON, CM ;

SARKAR, G ;

DONOVAN, KA ;

BAHN, RS .

THYROID, 1993, 3 (04) :297-300

[46] Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy [J].

Hiromatsu, Y ;

Yang, D ;

Bednarczuk, T ;

Miyake, I ;

Nonaka, K ;

Inoue, Y .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1194-1199

[47] Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154 - A randomized, double-blind, placebo-controlled trial [J].

Kalunian, KC ;

Davis, JC ;

Merrill, JT ;

Totoritis, MQ ;

Wofsy, D .

ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3251-3258

[48] Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes [J].

Keymeulen, B ;

Vandemeulebroucke, E ;

Ziegler, AG ;

Mathieu, C ;

Kaufman, L ;

Hale, G ;

Gorus, F ;

Goldman, M ;

Walter, M ;

Candon, S ;

Schandene, L ;

Crenier, L ;

De Block, C ;

Seigneurin, JM ;

De Pauw, P ;

Pierard, D ;

Weets, I ;

Rebello, P ;

Bird, P ;

Berrie, E ;

Frewin, M ;

Waldmann, H ;

Bach, JF ;

Pipeleers, D ;

Chatenoud, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (25) :2598-2608

[49] Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, natural history, and thyrotropin receptor antibody levels [J].

Khoo, DH ;

Eng, PH ;

Ho, SC ;

Tai, ES ;

Morgenthaler, NG ;

Seah, LL ;

Fong, KS ;

Chee, SP ;

Choo, CT ;

Aw, SE .

THYROID, 2000, 10 (12) :1093-1100

[50] Evidence for Enhanced Thy-1 (CD90) Expression in Orbital Fibroblasts of Patients with Graves' Ophthalmopathy [J].

Khoo, Teck Kim ;

Coenen, Michael J. ;

Schiefer, A. Reagan ;

Kumar, Seema ;

Bahn, Rebecca S. .

THYROID, 2008, 18 (12) :1291-1296

← 1 2 3 4 5 6 7 8 9 10 →